FDA Approves Apalutamide (Erleada); the first treatment for non-metastatic castration-resistant prostate cancer (READ MORE HERE).
Radiation therapy in combination with medicines that..
Robert Den, MD:
Kimmel Cancer Center, Thomas Jefferson University – Philadelphia, PA
Karen Knudsen, PhD, Associate Professor, Departments of Cancer Biology and Urology at the Kimmel Cancer Center, Thomas Jefferson University.
Adam Dicker, MD, PhD, Interim Chair and Professor, Radiation Research and Translational Biology, at the Kimmel Cancer Center, Thomas Jefferson University.
Combining PD-1 Mediated Checkpoint Blockade with Active..
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Maryland
Periprostatic Fat as a Promoter of Prostate..
NorthShore University HealthSystem Research Institute, Illinois
DNA-binding Polyamides as Inhibitors of TMPRSS2-ERG Activity..
Bren Professor of Chemistry
California Institute of Technology
Evaluation of Bindarit, a Novel Inhibitor of..
Professor, Pharmacology & Molecular Sciences
The Johns Hopkins University School of Medicine
Prostate cancer diagnosis and precision medicine treatment..
Jeremy Durack, MD, MS:
Memorial Sloan-Kettering Cancer Center
Howard Scher, MD
Rapid Spectroscopic Assessment of Targeted Prostate Cancer Biopsy Sufficiency at the Point-of-Care
Dr. Dehm completed a BS and PhD..
Scott M. Dehm, PhD:
Masonic Cancer Center, University of Minnesota – Minneapolis, MN
Men with progressive metastatic prostate cancer are..
Justin Drake, PhD:
Rutgers University Cancer Institute of New Jersey
Robert DiPaola, MD
Elucidating Kinase Activation Pathways in Advanced Prostate Cancer
Former Founder and Chairman
Sun Products Corporation